Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
  1. SC 13G Stake Amended Statement of Ownership
  2. 4 Insider Changes in Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13D Stake Beneficial Ownership Report
  7. 8-K Event Bylaws or fiscal year change · Shareholder vote results · Other events
  8. 424B5 Offering Prospectus
  9. EFFECT Other Notice of Effectiveness
  10. UPLOAD Other SEC-generated Letter
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. UPLOAD Other SEC-generated Letter
  13. SC 13G Stake Amended Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  16. S-3 Offering Registration Statement
  17. DEF 14A Proxy Proxy Statement
  18. 424B5 Offering Prospectus
  19. 8-K Event Other events
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 20 of 41 · 819 filings